Deep vein thrombosis
Disease7 papers7 findings
- Human trial1
- Humans6
Upstream
2Body mass index
mediatesin humans1
1 study
Body mass index
mediatesin humans1
Body mass index mediates deep vein thrombosis in humans (7.58% - 10.50% of ALM-DVT, 52.74% - 62.73% of LFM-DVT).
Humansmediates ALM-DVT and LFM-DVT effect
Genetically Predicted Muscle Mass and Function in Relation to Deep Vein Thrombosis: A Two-step Mendelian Randomization Study Highlighting the Mediating Role of BMI · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 10 Sep 2026
Grip strength
no changein humans1
1 study
Grip strength
no changein humans1
Grip strength has no effect on deep vein thrombosis in humans.
Humans
Genetically Predicted Muscle Mass and Function in Relation to Deep Vein Thrombosis: A Two-step Mendelian Randomization Study Highlighting the Mediating Role of BMI · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 10 Sep 2026
Associations
4GLP-1 receptor agonists
downin humans2HR 0.642Low certainty
2 studies
GLP-1 receptor agonists
downin humans2HR 0.642Low certainty
GLP-1 receptor agonists lower the risk of deep vein thrombosis in humans (HR 0.642, 95% CI 0.586-0.702).
Humanspatients with type 2 diabetes and inflammatory bowel diseasen = 32,236
Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study · PloS one · 24 Sep 2026
GLP-1 receptor agonists lower the risk of deep vein thrombosis in humans (RR 0.53, 95% CI 0.31-0.89).
Humans90-day
Preoperative GLP-1 receptor agonist use and outcomes after total hip arthroplasty: a matched cohort study · Hip international : the journal of clinical and experimental research on hip pathology and therapy · 11 Sep 2026
Leg fat-free mass
upin humans1OR 1.92–1.954
1 study
Leg fat-free mass
upin humans1OR 1.92–1.954
Leg fat-free mass raises the risk of deep vein thrombosis in humans (OR = 1.920-1.954).
Humans
Genetically Predicted Muscle Mass and Function in Relation to Deep Vein Thrombosis: A Two-step Mendelian Randomization Study Highlighting the Mediating Role of BMI · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 10 Sep 2026
Appendicular lean mass
upin humans1OR 1.288
1 study
Appendicular lean mass
upin humans1OR 1.288
Appendicular lean mass raises the risk of deep vein thrombosis in humans (OR 1.288, 95% CI 1.215-1.365).
Humansin FinnGen
Genetically Predicted Muscle Mass and Function in Relation to Deep Vein Thrombosis: A Two-step Mendelian Randomization Study Highlighting the Mediating Role of BMI · Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis · 10 Sep 2026
Exercise
downin humans1Low certainty
1 study
Exercise
downin humans1Low certainty
Exercise lowers the risk of deep vein thrombosis in humans.
Humans
Association between preoperative physical exercise and the risk of postoperative venous thromboembolism: nationwide population-based cohort study · BJS open · 4 Sep 2026
Trial sponsors
Company4 trialsPhase 312,756 people
Company3 trialsPhase 38,667 people
Company1 trialPhase 380 people
Company1 trialPhase 360 people
Company1 trialPhase 2961 people
Azienda Ospedaliera Universitaria Policlinico
2 trialsPhase 4750 people
Hallym University Medical Center
1 trialPhase 4180 people
1 trialPhase 467 people